|
May 12
|
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
|
|
May 12
|
1 Passive Income Vehicle Every Investor Should Own
|
|
May 10
|
Prediction: 3 Sensational Stocks That'll Be Worth Far More Than Tesla 2 Years From Now
|
|
May 9
|
Johnson & Johnson (NYSE:JNJ) Is Increasing Its Dividend To $1.24
|
|
May 9
|
3 Reliable Dividend Stocks For Long-Term Passive Income
|
|
May 9
|
What Is the Dividend Payout for Johnson & Johnson Stock?
|
|
May 8
|
10 Future Dividend Kings in the Next 5 Years or Less
|
|
May 8
|
Analysts' 3 Favorite Dividend Aristocrats, Based On Latest Price Targets
|
|
May 8
|
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
|
|
May 8
|
Neutrogena Lost Dermatologists and Missed Out on the $42 Billion Beauty Boom
|
|
May 8
|
The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
|
|
May 7
|
15 Best S&P 500 Dividend Stocks To Buy Now
|
|
May 7
|
Q1 Earnings Season Scorecard and Fresh Analyst Reports for Tesla, JNJ & Netflix
|
|
May 7
|
A Look at Pharma ETFs Post Q1 Earnings
|
|
May 7
|
Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
|
|
May 7
|
With 71% ownership, Johnson & Johnson (NYSE:JNJ) boasts of strong institutional backing
|
|
May 7
|
Time To Buy Johnson & Johnson? One Analyst Sees The Stock's Price Gaining Over 40%
|
|
May 7
|
Beyond the Balance Sheet: What SWOT Reveals About Shockwave Medical Inc (SWAV)
|
|
May 6
|
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
|
|
May 6
|
Shockwave Medical Reports First Quarter 2024 Financial Results
|